Public Calendar: August 18-24, 2024
This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.
Official Name: Robert M. Califf, M.D., MACC, Commissioner for Food and Drugs
No Significant Event
Official Name: Namandjé N. Bumpus, Ph.D., Principal Deputy Commissioner
No Significant Event
Official Name: Jim Jones, Deputy Commissioner for Human Foods
Event Date: 08/19/2024
Location: Tysons, VA
Subject: Food Safety and Nutrition Issues of Mutual Interest
FDA Participant/Group: KARI BARRETT; ADAM FRIEDLANDER; LAURA CARROLL;
Non FDA Participant/Group: Brian Olney, Colleen Wegman, Danny Wegman, Dave Corsi (Wegmans Food Markets, Inc.);
Event Date: 08/20/2024
Location: Virtual
Subject: FDA's Human Foods Program and Food Code
FDA Participant/Group: N/A
Non FDA Participant/Group: Association of State and Territorial Health Officials staff and members
Event Date: 08/21/2024
Location: College Park, MD
Subject: Food Traceability and Agricultural Water
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: The Leafy Greens Safety Coalition including representatives from Costco, Kroger, Walmart, Wegmans, Yum Brands, H-E-B, and McDonald’s
Official Name: Kimberlee Trzeciak, Deputy Commissioner for Policy, Legislation, and International Affairs
No Significant Event
Official Name: Jim Sigg, Deputy Commissioner for Operations
No Significant Event
Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy
No Significant Event
Official Name: Michael Rogers, Associate Commissioner for Regulatory Affairs
No Significant Event
Official Name: Leah Hunter, Associate Commissioner for External Affairs
No Significant Event
Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research
Event Date: 08/20/2024
Location: Virtual
Subject: Program Updates
FDA Participant/Group: JACQUELINE CORRIGAN CURAY; LYNDSAY HENNESSEY; CHRISTINE NGUYEN;
Non FDA Participant/Group: Courtney Silverthorn, David Carmel, Erika Jones, Joe Menetski, Julie Gerberding, Love Collins, Mike Santos, Stacey Adam, Steve Hoffmann (Foundation for the National Institutes of Health (FNIH));
Event Date: 08/20/2024
Location: Washington, DC
Subject: Continual Improvement of CDER Biologics License Application (BLA) Submission, Assessment, and Facility Readiness/Inspection: Chemistry, Manufacturing, and Controls (CMC) for Biologics and Biosimilars
FDA Participant/Group: N/A
Non FDA Participant/Group: Members of Duke University Margolis Institute for Health Policy
Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research
Event Date: 08/22/2024
Location: Virtual
Subject: Biocom California Joint Committee Meeting of the Cell and Gene Therapy and Regulatory Affairs Committees; Update on FDA’s Cell and Gene Therapy Initiatives and Regulatory Policy Advancements
FDA Participant/Group: N/A
Non FDA Participant/Group: Representatives from Biocom California Regulatory Affairs Committee and Biocom California industry members engaged in cell and/or gene therapy
Official Name: Michelle Tarver, M.D., Ph.D,, Acting Director, Center for Devices and Radiological Health
No Significant Event
Official Name: Donald Prater, Acting Director, Center for Food Safety and Applied Nutrition
No Significant Event
Official Name: Brian King, Ph.D., Director, Center for Tobacco Products
Event Date: 08/22/2024
Location: Virtual
Subject: Senate Ag-FDA Appropriations Majority Briefing; FDA Tobacco Overview and Programmatic Updates
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several staff from the Senate Ag-FDA Appropriations Committee (No sitting members attended)
Official Name: Tracey H. Forfa, J.D., Director, Center for Veterinary Medicine
No Significant Event
Official Name: Tucker Patterson, Ph.D., Director, National Center for Toxicological Research
No Significant Event
Official Name: Mark Raza, J.D., Chief Counsel
No Significant Event